Search Results for "Pregnancy"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Pregnancy. Results 341 to 350 of 981 total matches.

Treatment of Clostridioides difficile Infection

   
The Medical Letter on Drugs and Therapeutics • Sep 06, 2021  (Issue 1632)
of rifaximin could alter the INR. PREGNANCY AND LACTATION — Use of oral vancomycin or fidaxomicin ...
Clostridioides (formerly Clostridium) difficile infection (CDI) is the most common infectious cause of healthcare-associated diarrhea in adults. Guidelines on management of CDI have recently been updated.
Med Lett Drugs Ther. 2021 Sep 6;63(1632):137-41 |  Show IntroductionHide Introduction

Antiviral Drugs for Seasonal Influenza for 2024-2025

   
The Medical Letter on Drugs and Therapeutics • Dec 09, 2024  (Issue 1717)
should be continued for up to 1 week after the end of the outbreak. PREGNANCY AND LACTATION — Pregnant ...
Influenza is generally a self-limited illness, but pneumonia, respiratory failure, and death can occur, especially in persons at increased risk for influenza complications (see Table 1). Updated information on influenza activity and antiviral resistance is available from the CDC at cdc.gov/flu.
Med Lett Drugs Ther. 2024 Dec 9;66(1717):193-8   doi:10.58347/tml.2024.1717a |  Show IntroductionHide Introduction

Comparison Table: Some Oral Antiseizure Medications (online only)

   
The Medical Letter on Drugs and Therapeutics • Aug 05, 2024  (Issue 1708)
, and phenobarbital can decrease felbamate levels No adequate pregnancy or lactation studies in humans; decreased ...
View the Comparison Table: Some Oral Antiseizure Medications
Med Lett Drugs Ther. 2024 Aug 5;66(1708):e133-40   doi:10.58347/tml.2024.1708b |  Show IntroductionHide Introduction

Prosthetic Heart Valves

   
The Medical Letter on Drugs and Therapeutics • Aug 20, 2012  (Issue 1397)
complicating a pregnancy with anticoagulation. CONCLUSION — Bioprosthetic valves are preferred for patients ...
Prosthetic heart valves have been used effectively in patients with mitral and aortic valvular heart disease for more than 50 years, but no replacement valve developed to date is suitable for all types of patients.
Med Lett Drugs Ther. 2012 Aug 20;54(1397):67 |  Show IntroductionHide Introduction

In Brief: Esomeprazole Strontium

   
The Medical Letter on Drugs and Therapeutics • Jul 21, 2014  (Issue 1447)
into bone. It is not recommended for use in children or during pregnancy because of the absence of safety ...
The FDA has approved the proton pump inhibitor (PPI) esomeprazole strontium for use in adults for the same indications as esomeprazole magnesium (Nexium): treatment of gastroesophageal reflux disease (GERD), prevention of NSAID-induced gastric ulcers, eradication of Helicobacter pylori, and treatment of pathological hypersecretory conditions. It was first marketed in December 2013 as a branded drug (Esomeprazole Strontium) and a month later as a generic drug.Strontium is incorporated into bone. It is not recommended for use in children or during pregnancy because of the absence of safety data...
Med Lett Drugs Ther. 2014 Jul 21;56(1447):64 |  Show IntroductionHide Introduction

In Brief: Adstiladrin – A Gene Therapy for Bladder Cancer (online only)

   
The Medical Letter on Drugs and Therapeutics • Mar 06, 2023  (Issue 1671)
infection in immunocompromised patients. PREGNANCY AND LACTATION — Nadofaragene firadenovec ...
Nadofaragene firadenovec-vncg (Adstiladrin – Ferring), an adenoviral vector-based gene therapy, has been approved by the FDA for treatment of adults with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ with or without papillary tumors. It is the first adenoviral vector-based gene therapy to be approved in the US for this indication. The immune checkpoint inhibitor pembrolizumab (Keytruda) was approved for the same indication in 2021.
Med Lett Drugs Ther. 2023 Mar 6;65(1671):e40-1   doi:10.58347/tml.2023.1671e |  Show IntroductionHide Introduction

In Brief: Anktiva for Bladder Cancer (online only)

   
The Medical Letter on Drugs and Therapeutics • Jun 24, 2024  (Issue 1705)
hours after receiving Anktiva and BCG. PREGNANCY AND LACTATION — Nogapendekin alfa inbakicept ...
Nogapendekin alfa inbakicept-pmln (Anktiva – ImmunityBio), a first-in-class interleukin-15 (IL15) receptor agonist, has been approved by the FDA for use with Bacillus Calmette-Guérin (BCG) for treatment of patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ with or without papillary tumors. Such patients generally undergo bladder tumor resection, followed by intravesical BCG treatment, but treatment failure and cancer recurrence are common. The adenoviral vector-based intravesical gene therapy nadofaragene firadenovec-vncg (Adstiladrin)...
Med Lett Drugs Ther. 2024 Jun 24;66(1705):e105-6   doi:10.58347/tml.2024.1705e |  Show IntroductionHide Introduction

Valproate and Other Anticonvulsants For Psychiatric Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 11, 2000  (Issue 1094)
IN PREGNANCY — Fetal exposure to phenytoin, carbamazepine, valproate, phenobarbital and other older ...
Anticonvulsants are now widely used for treatment of psychiatric illnesses, particularly bipolar disorder. Lithium is the standard drug for treatment of bipolar disorder, but it can cause severe toxicity, serum concentrations must be monitored, and it is not effective in some patients.
Med Lett Drugs Ther. 2000 Dec 11;42(1094):114-5 |  Show IntroductionHide Introduction

Rifaximin (Xifaxan) for Travelers' Diarrhea

   
The Medical Letter on Drugs and Therapeutics • Sep 13, 2004  (Issue 1191)
, and should not be taken during pregnancy. • For severe diarrhea, a fluoroquinolone is preferred. PAGE 74 ...
Rifaximin (Xifaxan - Salix), a non-absorbed oral antibiotic derived from rifampin (Rifadin, and others), has been approved by the FDA for treatment of travelers' diarrhea caused by noninvasive strains of Escherichia coli in patients 12 years of age or older. It has been available in Europe since 1987.
Med Lett Drugs Ther. 2004 Sep 13;46(1191):74-5 |  Show IntroductionHide Introduction

A New Indication for Gamma Hydroxybutyrate (Xyrem) in Narcolepsy

   
The Medical Letter on Drugs and Therapeutics • Jan 30, 2006  (Issue 1227)
incontinence and sleepwalking also occurred. GHB’s safety in pregnancy and breastfeeding are unknown ...
Gamma hydroxybutyrate (GHB), a central-nervous-system depressant notorious for its use in "date rape", was approved by the FDA in 2002 as sodium oxybate (Xyrem - Jazz Pharmaceuticals) for oral treatment of cataplexy in patients with narcolepsy. Now it has also been approved for treatment of excessive daytime sleepiness (EDS) in these patients. Xyrem is a Schedule III controlled substance.
Med Lett Drugs Ther. 2006 Jan 30;48(1227):11-2 |  Show IntroductionHide Introduction